List of Excipients in API irbesartan and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing irbesartan and hydrochlorothiazide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| sanofi-aventis US LLC | AVALIDE | irbesartan and hydrochlorothiazide | 0024-5855 | CARNAUBA WAX | |
| sanofi-aventis US LLC | AVALIDE | irbesartan and hydrochlorothiazide | 0024-5855 | CELLULOSE, MICROCRYSTALLINE | |
| sanofi-aventis US LLC | AVALIDE | irbesartan and hydrochlorothiazide | 0024-5855 | CROSCARMELLOSE SODIUM | |
| sanofi-aventis US LLC | AVALIDE | irbesartan and hydrochlorothiazide | 0024-5855 | FERRIC OXIDE RED | |
| sanofi-aventis US LLC | AVALIDE | irbesartan and hydrochlorothiazide | 0024-5855 | FERRIC OXIDE YELLOW | |
| sanofi-aventis US LLC | AVALIDE | irbesartan and hydrochlorothiazide | 0024-5855 | HYPROMELLOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing irbesartan and hydrochlorothiazide
Detailed excipient profiles for irbesartan and hydrochlorothiazide
Excipient focus: CARBOXYMETHYLCELLULOSE CALCIUM
irbesartan and hydrochlorothiazide drug variants containing CARBOXYMETHYLCELLULOSE CALCIUM
irbesartan and hydrochlorothiazide drug variants not containing CARBOXYMETHYLCELLULOSE CALCIUM
Excipient focus: CARNAUBA WAX
irbesartan and hydrochlorothiazide drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | irbesartan and hydrochlorothiazide | 0024-5855 |
| Winthrop US a business of sanofi-aventis US LLC | irbesartan and hydrochlorothiazide | 0955-1045 |
| Bryant Ranch Prepack | irbesartan and hydrochlorothiazide | 71335-1392 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
irbesartan and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
irbesartan and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
irbesartan and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
irbesartan and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
irbesartan and hydrochlorothiazide drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
irbesartan and hydrochlorothiazide drug variants containing FERRIC OXIDE RED
irbesartan and hydrochlorothiazide drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
irbesartan and hydrochlorothiazide drug variants containing FERRIC OXIDE YELLOW
irbesartan and hydrochlorothiazide drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
irbesartan and hydrochlorothiazide drug variants containing FERROSOFERRIC OXIDE
irbesartan and hydrochlorothiazide drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
irbesartan and hydrochlorothiazide drug variants containing HYPROMELLOSE
irbesartan and hydrochlorothiazide drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
irbesartan and hydrochlorothiazide drug variants containing HYPROMELLOSE 2910
irbesartan and hydrochlorothiazide drug variants not containing HYPROMELLOSE 2910
Excipient focus: LACTOSE MONOHYDRATE
irbesartan and hydrochlorothiazide drug variants containing LACTOSE MONOHYDRATE
irbesartan and hydrochlorothiazide drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: LECITHIN, SOYBEAN
irbesartan and hydrochlorothiazide drug variants containing LECITHIN, SOYBEAN
irbesartan and hydrochlorothiazide drug variants not containing LECITHIN, SOYBEAN
Excipient focus: MAGNESIUM STEARATE
irbesartan and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
irbesartan and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | irbesartan and hydrochlorothiazide | 65862-629 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
irbesartan and hydrochlorothiazide drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Unichem Pharmaceuticals (USA) Inc | irbesartan and hydrochlorothiazide | 29300-215 |
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing MANNITOL
Excipient focus: POLOXAMER 188
irbesartan and hydrochlorothiazide drug variants containing POLOXAMER 188
irbesartan and hydrochlorothiazide drug variants not containing POLOXAMER 188
Excipient focus: POLYETHYLENE GLYCOL
irbesartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| sanofi-aventis US LLC | irbesartan and hydrochlorothiazide | 0024-5855 |
| Winthrop US a business of sanofi-aventis US LLC | irbesartan and hydrochlorothiazide | 0955-1045 |
| Bryant Ranch Prepack | irbesartan and hydrochlorothiazide | 71335-1392 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3000
irbesartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3000
irbesartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3000
Excipient focus: POLYETHYLENE GLYCOL 3350
irbesartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 3350
irbesartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
irbesartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 400
irbesartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
irbesartan and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL 6000
irbesartan and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYVINYL ALCOHOL
irbesartan and hydrochlorothiazide drug variants containing POLYVINYL ALCOHOL
irbesartan and hydrochlorothiazide drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
irbesartan and hydrochlorothiazide drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
irbesartan and hydrochlorothiazide drug variants containing POVIDONE K25
irbesartan and hydrochlorothiazide drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K29/32
irbesartan and hydrochlorothiazide drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | irbesartan and hydrochlorothiazide | 33342-057 |
| Physicians Total Care Inc | irbesartan and hydrochlorothiazide | 54868-6457 |
| Bryant Ranch Prepack | irbesartan and hydrochlorothiazide | 63629-7468 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K30
irbesartan and hydrochlorothiazide drug variants containing POVIDONE K30
irbesartan and hydrochlorothiazide drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
irbesartan and hydrochlorothiazide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
irbesartan and hydrochlorothiazide drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| LUPIN LIMITED | irbesartan and hydrochlorothiazide | 57297-413 |
| Lupin Pharmaceuticals Inc | irbesartan and hydrochlorothiazide | 68180-413 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
irbesartan and hydrochlorothiazide drug variants containing SILICON DIOXIDE
irbesartan and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
irbesartan and hydrochlorothiazide drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
irbesartan and hydrochlorothiazide drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
irbesartan and hydrochlorothiazide drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | irbesartan and hydrochlorothiazide | 65862-629 |
| >Company | >Ingredient | >NDC |
irbesartan and hydrochlorothiazide drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
irbesartan and hydrochlorothiazide drug variants containing STARCH, CORN
irbesartan and hydrochlorothiazide drug variants not containing STARCH, CORN
Excipient focus: TALC
irbesartan and hydrochlorothiazide drug variants containing TALC
irbesartan and hydrochlorothiazide drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
irbesartan and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
irbesartan and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
